Page last updated: 2024-11-02

phenoxybenzamine and B-Cell Chronic Lymphocytic Leukemia

phenoxybenzamine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Research Excerpts

ExcerptRelevanceReference
"Phenoxybenzamine treatment enabled his indwelling catheter to be discarded in favour of a penile sheath, but it caused unacceptable dizziness and was stopped after 7 years."1.33Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy. ( Hughes, PL; Mansour, P; Singh, G; Soni, BM; Vaidyanathan, S, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaidyanathan, S1
Mansour, P1
Soni, BM1
Hughes, PL1
Singh, G1

Other Studies

1 other study available for phenoxybenzamine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy.
    Spinal cord, 2006, Volume: 44, Issue:3

    Topics: Adult; Carcinoma, Small Cell; CD56 Antigen; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chr

2006